Come up with a name for your new list and we'll add to it:
AbSci raised a round of funding on April 12, 2016. Investors include
Phoenix Venture Partners.
AbSci is focused in protein production technologies committed to reducing costs in the biopharmaceutical industry. The company's SoluPro expression platform achieves yields of soluble and active prote…